SCHEMBL25848274

SCHEMBL25848274

C=CC(=O)OC1CCC(Oc2ccc3cc(-c4ccccc4)c(=O)oc3c2)C1(C)C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 8/20 0.53
RAB9A P51151 7/20 0.53
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
KDM4E B2RXH2 2/20 0.53
GLA P06280 2/20 0.53
KLK7 P49862 1/20 0.48
ALDH1A1 P00352 1/20 0.48
GAA P10253 1/20 0.48
HPGD P15428 1/20 0.48
RECQL P46063 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
HSD17B10 Q99714 1/20 0.48
MIF P14174 2/20 0.43
RXFP1 Q9HBX9 3/20 0.43
POLB P06746 2/20 0.42
CASP3 P42574 1/20 0.42
SENP8 Q96LD8 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
SENP6 Q9GZR1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22625067 0.89 NPC1 (0.48) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL21734943 0.89 HDAC6 (0.39) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL25848277 0.89 RAB9A (0.41) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL25848276 0.87 NPC1 (0.55) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL25848295 0.84 RAB9A (0.41) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL25848565 0.84 NPC1 (0.58) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL25848248 0.83 NPC1 (0.53) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL25848299 0.80 RAB9A (0.38) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL25848279 0.80 THRB (0.41) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL22624932 0.79 NPC1 (0.49) NPC1RAB9AMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11702396-B2 Hydrophobic compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2023-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11702396-B2 Hydrophobic compounds for optically active devices UACA, CRYZ, TRPA1 NPC1 1051/4885RAB9A 1916/4885MEN1 3033/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.